Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

A Long-Term Safety and Tolerability Study in Subjects With Mild to Moderate Alzheimer's Disease

26. november 2013 oppdatert av: JANSSEN Alzheimer Immunotherapy Research & Development, LLC

A Phase 3 Extension, Multicenter, Double-Blind, Long-Term Safety and Tolerability Treatment Trial of Bapineuzumab (AAB-001, ELN115727) in Subjects With Alzheimer's Disease Who Participated in Study ELN115727-301 or Study ELN115727-302.

The purpose of this study is to assess the long-term safety and tolerability of Bapineuzumab (AAB-001, ELN115727) in subjects with Alzheimer's disease who participated in study ELN115727-301 or study ELN115727-302.

Studieoversikt

Status

Avsluttet

Forhold

Intervensjon / Behandling

Studietype

Intervensjonell

Registrering (Faktiske)

896

Fase

  • Fase 3

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiesteder

  • Canada
    • Alberta
      • Calgary, Alberta, Canada, T2N 4Z6
        • University of Calgary, Foothills Medical Centre
    • British Columbia
      • Kamloops, British Columbia, Canada, V2C 1K7
        • Medical Arts Health Research Group
      • Kelowna, British Columbia, Canada, V1Y 3G8
        • Medical Arts Health Research Group
    • Ontario
      • Kingston, Ontario, Canada, K7L 5G2
        • Queens University Memorial Clinics
      • London, Ontario, Canada, N6C 5J1
        • Parkwood Hospital
      • Ottawa, Ontario, Canada, K1N 5C8
        • Bruyère Continuing Care
      • Toronto, Ontario, Canada, M3B 2S7
        • Neurology Research Inc
      • Toronto, Ontario, Canada, M6M 3Z5
        • Toronto Centre for Memory and Aging
      • Whitby, Ontario, Canada, L1N 5S9
        • Ontario Shores Centre for Mental Health Sciences
    • Quebec
      • Greenfield Park, Quebec, Canada, J4V 2J2
        • Neuro Rive-Sud Memory Clinic
      • Montréal, Quebec, Canada, H1T 2M4
        • Hôpital Maisonneuve-Rosemont
      • Montréal, Quebec, Canada, H3T 1E2
        • Sir Mortimer B. Davis, Jewish General Hospital
      • Sherbrooke, Quebec, Canada, J1H 1Z1
        • Diex Research Sherbrooke Inc.
      • Verdun, Quebec, Canada, H4H 1R3
        • Douglas Mental Health University Institute
  • Forente stater
    • Alabama
      • Birmingham, Alabama, Forente stater, 35205
        • University of Alabama Hospital
    • Arizona
      • Goodyear, Arizona, Forente stater, 85395
        • Dedicated Clinical Research, Inc.
      • Phoenix, Arizona, Forente stater, 85006
        • Banner Alzheimer's Institute
      • Phoenix, Arizona, Forente stater, 85050
        • HOPE Research Institute, LLC
      • Sun City, Arizona, Forente stater, 85351
        • Banner Research Institute
      • Tucson, Arizona, Forente stater, 85724
        • University of Arizona College of Medicine, Health Sciences Center
      • Tucson, Arizona, Forente stater, 85741
        • Northwest NeuroSpecialists, PLLC
    • Arkansas
      • Little Rock, Arkansas, Forente stater, 72205
        • Clinical Trials, Inc.
    • California
      • Berkeley, California, Forente stater, 94705
        • East Bay Physicians Medical Group
      • Carson, California, Forente stater, 90746
        • AVI Clinical Research
      • Costa Mesa, California, Forente stater, 92626
        • ATP Clinical Research, Inc.
      • Encino, California, Forente stater, 91316
        • Pharmacology Research Institute
      • Fresno, California, Forente stater, 93720
        • Margolin Brain Institute
      • Fullerton, California, Forente stater, 92835
        • Neurology Center of North Orange County
      • La Jolla, California, Forente stater, 92037
        • University of California San Diego
      • La Jolla, California, Forente stater, 92037
        • Coordinated Clinical Research
      • Laguna Hills, California, Forente stater, 92653
        • Senior Clinical Trials, Inc.
      • Long Beach, California, Forente stater, 90806
        • Collaborative Neuroscience Network, Inc.
      • Los Alamitos, California, Forente stater, 90720
        • Pharmacology Research Institute
      • Los Angeles, California, Forente stater, 90095
        • UCLA Department of Neurology
      • Newport Beach, California, Forente stater, 92660
        • Pharmacology Research Institute
      • Oceanside, California, Forente stater, 92056
        • Neurology Center
      • Orange, California, Forente stater, 92868
        • University of California, Irvine Medical Center
      • Pasadena, California, Forente stater, 91105
        • Neuro-Therapeutics, Inc.
      • Sacramento, California, Forente stater, 95816
        • Sutter Neuroscience Medical Group
      • Sacramento, California, Forente stater, 95817
        • University of California at Davis, Alzheimer's Disease Research Center
      • San Diego, California, Forente stater, 92123
        • Sharp Mesa Vista Hospital
      • San Diego, California, Forente stater, 92123
        • Artemis Institute for Clinical Research
      • San Francisco, California, Forente stater, 94143
        • University of California San Francisco
      • San Francisco, California, Forente stater, 94109
        • San Francisco Clinical Research Center
      • Santa Monica, California, Forente stater, 90404
        • Neurological Research Institute
      • Sherman Oaks, California, Forente stater, 91403
        • Schuster Medical Research Institute
      • Walnut Creek, California, Forente stater, 94596
        • Diablo Clinical Research, Inc
    • Colorado
      • Boulder, Colorado, Forente stater, 80304
        • Alpine Clinical Research Center
      • Denver, Colorado, Forente stater, 80218
        • Mile High Research Center
      • Fort Collins, Colorado, Forente stater, 80528
        • Advanced Neurosciences Research, Llc
    • Connecticut
      • Danbury, Connecticut, Forente stater, 06810
        • Associated Neurologists, PC
      • Fairfield, Connecticut, Forente stater, 06824
        • Associated Neurologists of Southern Connecticut, P.C.
      • New Haven, Connecticut, Forente stater, 06510
        • Yale University School of Medicine
      • New Haven, Connecticut, Forente stater, 06510
        • Institute For Neurodegenerative Disorders
      • Norwalk, Connecticut, Forente stater, 06851
        • Research Center for Clinical Studies, Inc.
      • Waterbury, Connecticut, Forente stater, 06708
        • Chase Medical Research, LLC
    • Delaware
      • Newark, Delaware, Forente stater, 19713
        • Christiana Care Neurology Specialists
    • District of Columbia
      • Washington, District of Columbia, Forente stater, 20057
        • Georgetown University Medical Center
    • Florida
      • Atlantis, Florida, Forente stater, 33462
        • JEM Research, LLC
      • Bradenton, Florida, Forente stater, 34205
        • Bradenton Research Center, Inc.
      • Deerfield Beach, Florida, Forente stater, 33064
        • Quantum Laboratories, Inc.
      • Delray Beach, Florida, Forente stater, 33445
        • Brain Matters Research
      • Fort Lauderdale, Florida, Forente stater, 33308
        • Neurologic Consultants, PA
      • Fort Myers, Florida, Forente stater, 33912
        • Neuropsychiatric Research Center of Southwest Florida
      • Fort Myers, Florida, Forente stater, 33916
        • Clinical Physiology Associates, Inc
      • Fort Walton Beach, Florida, Forente stater, 32547
        • Emerald Coast Mood and Memory, PA.
      • Hallandale Beach, Florida, Forente stater, 33009
        • MD Clinical
      • Jacksonville, Florida, Forente stater, 32224
        • Mayo Clinic College of Medicine
      • Maitland, Florida, Forente stater, 32751
        • Neurology Associates
      • Melbourne, Florida, Forente stater, 32901
        • Melbourne Internal Medicine Associates
      • Miami, Florida, Forente stater, 33137
        • Miami Jewish Health Systems
      • Miami, Florida, Forente stater, 33173
        • Miami Research Associates
      • Miami, Florida, Forente stater, 33126
        • Pharmax Research Clinic, LLC
      • Miami, Florida, Forente stater, 33156
        • Allied Clinical Trials Inc.
      • Ocala, Florida, Forente stater, 34471
        • Renstar Medical Research
      • Orlando, Florida, Forente stater, 32806
        • Compass Research, LLC
      • Palm Beach Gardens, Florida, Forente stater, 33418
        • Palm Beach Neurological Center, Advanced Research Consultants, Inc.
      • Port Charlotte, Florida, Forente stater, 33952
        • Neurostudies, Inc.
      • Saint Petersburg, Florida, Forente stater, 33713
        • Suncoast Neuroscience Associates, Inc.
      • Sarasota, Florida, Forente stater, 34243
        • The Roskamp Institute, Inc
      • Tampa, Florida, Forente stater, 33609
        • Axiom Clinical Research of Florida
      • Tampa, Florida, Forente stater, 33613
        • Stedman Clinical Trials, LLC
      • Tampa, Florida, Forente stater, 33613
        • Johnnie B. Byrd Sr. Alzheimer's Center and Research Institute
      • Tampa, Florida, Forente stater, 33613
        • University of South Florida Suncoast Alzheimer's and Gerontology Center
      • West Palm Beach, Florida, Forente stater, 33407
        • Premiere Research Institute
    • Georgia
      • Atlanta, Georgia, Forente stater, 30342
        • NeuroTrials Research, Inc.
      • Atlanta, Georgia, Forente stater, 30322
        • Emory University, School of Medicine
      • Atlanta, Georgia, Forente stater, 30327
        • Multiple Sclerosis Center of Atlanta
      • Columbus, Georgia, Forente stater, 31909
        • Medical Research and Health Education Foundation, Inc.
      • Columbus, Georgia, Forente stater, 31909
        • Medical Research and Health Education Foundation, Inc
      • Decatur, Georgia, Forente stater, 30033
        • Dekalb Neurology Associates, LLC
      • Lawrenceville, Georgia, Forente stater, 30045
        • Gwinnett Medical Center
    • Illinois
      • Chicago, Illinois, Forente stater, 60637
        • University of Chicago Medical Center
      • Elk Grove Village, Illinois, Forente stater, 60007
        • Alexian Brothers Neuroscience Institute
      • Peoria, Illinois, Forente stater, 61602
        • Methodist Medical Center of Illinois
      • Springfield, Illinois, Forente stater, 62794
        • Southern Illinois University School of Medicine
    • Indiana
      • Elkhart, Indiana, Forente stater, 46514
        • Elkhart Clinic, LLC
      • Indianapolis, Indiana, Forente stater, 46202
        • Indiana University School of Medicine
    • Kansas
      • Kansas City, Kansas, Forente stater, 66160
        • The University of Kansas Medical Center
      • Lenexa, Kansas, Forente stater, 66214
        • MidAmerica Neuroscience Institute
    • Kentucky
      • Lexington, Kentucky, Forente stater, 40536
        • University of Kentucky
      • Lexington, Kentucky, Forente stater, 40513
        • Associates in Neurology, PSC
      • Paducah, Kentucky, Forente stater, 42003
        • Four Rivers Clinical Research, Inc.
    • Louisiana
      • Lake Charles, Louisiana, Forente stater, 70629
        • Lake Charles Clinical Trials
      • Shreveport, Louisiana, Forente stater, 71104
        • J. Gary Booker, MD, APMC
    • Maine
      • Scarborough, Maine, Forente stater, 04074
        • Maine Medical Partners Neurology
    • Maryland
      • Rockville, Maryland, Forente stater, 20850
        • CBH Health, LLC
    • Massachusetts
      • Boston, Massachusetts, Forente stater, 02118
        • Boston University School of Medicine
      • Boston, Massachusetts, Forente stater, 02115
        • Brigham and Women's Hospital, Dept. of Neurology
      • Haverhill, Massachusetts, Forente stater, 01830
        • ActivMed Practices and Research, Inc.
      • Newton, Massachusetts, Forente stater, 02459
        • Neurocare, Inc.
      • Pittsfield, Massachusetts, Forente stater, 01201
        • Neuroscience Research of the Berkshires
      • Plymouth, Massachusetts, Forente stater, 02360
        • Donald S. Marks, MD, PC
      • Springfield, Massachusetts, Forente stater, 01104
        • Springfield Neurology Associates, LLC
    • Michigan
      • Ann Arbor, Michigan, Forente stater, 48105
        • University of Michigan Medical Center
      • Detroit, Michigan, Forente stater, 48202
        • Henry Ford Hospital
      • East Lansing, Michigan, Forente stater, 48824
        • Michigan State University
      • Kalamazoo, Michigan, Forente stater, 49048
        • Borgess Medical Center/Borgess Research Institute
    • Minnesota
      • Rochester, Minnesota, Forente stater, 55905
        • Mayo Clinic
    • Mississippi
      • Hattiesburg, Mississippi, Forente stater, 39401
        • Hattiesburg Clinic
    • Missouri
      • Kansas City, Missouri, Forente stater, 64114
        • Center For Pharmaceutical Research
      • Saint Louis, Missouri, Forente stater, 63104
        • Saint Louis University School of Medicine
      • Saint Lous, Missouri, Forente stater, 63108
        • Washington University School of Medicine
    • Montana
      • Billings, Montana, Forente stater, 59101
        • Deaconess Billings Clinical Research Center
      • Great Falls, Montana, Forente stater, 59405
        • Advanced Neurology Specialists
    • Nebraska
      • Omaha, Nebraska, Forente stater, 68198
        • University of Nebraska Medical Center
    • New Jersey
      • Eatontown, New Jersey, Forente stater, 07724
        • Memory Enhancement Center of America, Inc.
      • Manchester, New Jersey, Forente stater, 08759
        • Alzheimer's Research Corporation
      • Princeton, New Jersey, Forente stater, 08540
        • Global Medical Institutes, LLC
      • Toms River, New Jersey, Forente stater, 08755
        • Shore Neurology, PA
    • New Mexico
      • Albuquerque, New Mexico, Forente stater, 87109
        • Albuquerque Neuroscience, Inc.
    • New York
      • Albany, New York, Forente stater, 12205
        • Upstate Clinical Research, LLC
      • Albany, New York, Forente stater, 12208
        • Neurological Associates of Albany, PC
      • Albany, New York, Forente stater, 12208
        • Neuroscience Research Center at Albany Medical Center
      • Elmsford, New York, Forente stater, 10523
        • Advanced BioBehavioral Sciences
      • Latham, New York, Forente stater, 12110
        • Empire Neurology, PC
      • Liverpool, New York, Forente stater, 13088
        • Neurological Care of Central New York
      • New Hyde Park, New York, Forente stater, 11040
        • Parker Jewish Institute for Health Care and Rehabilitation
      • New York, New York, Forente stater, 10032
        • Columbia University Medical Center
      • New York, New York, Forente stater, 10016
        • New York University School of Medicine/Psychiarty
      • Orangeburg, New York, Forente stater, 10962
        • Nathan S. Kline Institute for Psychiatric Research
      • Rochester, New York, Forente stater, 14620
        • University of Rochester Medical Center, Monroe Community Hospital
    • North Carolina
      • Durham, North Carolina, Forente stater, 27710
        • Duke University Medical Center
      • Hickory, North Carolina, Forente stater, 28601
        • Clinical Trials of America, Inc
      • Raleigh, North Carolina, Forente stater, 27607
        • Raleigh Neurology Associates
    • Ohio
      • Canton, Ohio, Forente stater, 44718
        • Neuro-Behavioral Clinical Research, Inc.
      • Columbus, Ohio, Forente stater, 43210
        • Ohio State University, Dept. of Neurology
      • Dayton, Ohio, Forente stater, 45417
        • Neurology Specialists, Inc.
    • Oklahoma
      • Oklahoma City, Oklahoma, Forente stater, 73112
        • Lynn Health Science Institute
      • Oklahoma City, Oklahoma, Forente stater, 73112
        • Red River Medical Research Center, LLC
    • Oregon
      • Medford, Oregon, Forente stater, 97504
        • Providence Medical Group-Medford Neurology
      • Portland, Oregon, Forente stater, 97239
        • Oregon Health and Science University
      • Portland, Oregon, Forente stater, 97223
        • Summit Research Group, LLC
      • Portland, Oregon, Forente stater, 97225
        • Providence Health Service System, AD Center, Brain Institute
    • Pennsylvania
      • Abington, Pennsylvania, Forente stater, 19001
        • Abington Neurological Associates, Ltd.
      • Allentown, Pennsylvania, Forente stater, 18103
        • Lehigh Valley Health Network
      • Jenkintown, Pennsylvania, Forente stater, 19046
        • The Clinical Trial Center, LLC
      • Philadelphia, Pennsylvania, Forente stater, 19102
        • Drexel University College of Medicine
      • Philadelphia, Pennsylvania, Forente stater, 19104
        • Penn Memory Center
      • Philadelphia, Pennsylvania, Forente stater, 19107
        • Jefferson Hospital for Neuroscience
      • Pittsburgh, Pennsylvania, Forente stater, 15213
        • University of Pittsburgh
      • Pittsburgh, Pennsylvania, Forente stater, 15206
        • Clinical Trials Research Services, LLC
    • Rhode Island
      • East Providence, Rhode Island, Forente stater, 02914
        • Rhode Island Mood and Memory Research Institute
      • Providence, Rhode Island, Forente stater, 02903
        • Rhode Island Hospital
      • Providence, Rhode Island, Forente stater, 02906
        • Butler Hospital
    • South Carolina
      • North Charleston, South Carolina, Forente stater, 29406
        • Medical University of South Carolina
    • South Dakota
      • Sioux Falls, South Dakota, Forente stater, 57105
        • Avera Research Institute
    • Tennessee
      • Cordova, Tennessee, Forente stater, 38018
        • Neurology Clinic, P.C.
      • Johnson City, Tennessee, Forente stater, 37614
        • East Tennessee State University
      • Knoxville, Tennessee, Forente stater, 37920
        • Volunteer Research Group
      • Nashville, Tennessee, Forente stater, 37203
        • Psychiatric Consultants, PC
    • Texas
      • Austin, Texas, Forente stater, 78757
        • Senior Adults Specialty Research (Sasr)
      • Dallas, Texas, Forente stater, 75214
        • Texas Neurology, PA
      • Dallas, Texas, Forente stater, 75390
        • University of Texas Southwestern Medical Center, Dept. of Neurology
      • DeSoto, Texas, Forente stater, 75115
        • InSite Clinical Research
      • Fort Worth, Texas, Forente stater, 76106
        • University of North Texas Health Science Center at Fort Worth
      • Houston, Texas, Forente stater, 77030
        • Baylor College of Medicine
      • San Antonio, Texas, Forente stater, 78229
        • Innovative Clinical Trials
      • San Antonio, Texas, Forente stater, 78231
        • Integra Clinical Research, Llc
    • Utah
      • Salt Lake City, Utah, Forente stater, 84107
        • Wasatch Clinical Research
      • Salt Lake City, Utah, Forente stater, 84108
        • University of Utah, Dept. of Neurology
    • Vermont
      • Bennington, Vermont, Forente stater, 05201
        • The Memory Clinic
      • Burlington, Vermont, Forente stater, 05401
        • Fletcher Allen Health Care
    • Virginia
      • Alexandria, Virginia, Forente stater, 22304
        • Innovative Clinical Research Center
      • Charlottesville, Virginia, Forente stater, 22903
        • University of Virginia
      • Richmond, Virginia, Forente stater, 23230
        • Alliance Research Group, LLC
    • Washington
      • Seattle, Washington, Forente stater, 98108
        • University of Washington Veterans Affairs
      • Seattle, Washington, Forente stater, 98144
        • Pacific Medical Centers
    • Wisconsin
      • Milwaukee, Wisconsin, Forente stater, 53226
        • Medical College of Wisconsin, Froedtert Memorial Lutheran Hospital
      • Waukesha, Wisconsin, Forente stater, 53188
        • Independent Psychiatric Consultants
  • Østerrike
    • Styria
      • Graz, Styria, Østerrike, 8036
        • Landeskrankenhaus- Universitätsklinikum Graz

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

51 år og eldre (Voksen, Eldre voksen)

Tar imot friske frivillige

Nei

Kjønn som er kvalifisert for studier

Alle

Beskrivelse

Inclusion Criteria:

  • Diagnosis of probable AD
  • Must have completed study 301 or study 302; and have completed Visit 15 (Week 78)
  • Brain MRI scan to evaluate safety from Study 301 or 302 at Visit 14/Week 71
  • Caregiver able to attend all clinic visits with patient

Exclusion Criteria:

  • Any new medical contraindication or clinically significant abnormality on physical, neurological, laboratory, vital signs or ECG examination (eg, atrial fibrillation) that precludes continued or initiation of treatment with bapineuzumab or participation in the study
  • Screening visit brain MRI scan (MRI from Study 301 or 302 Visit 14/Week 71) indicative of any significant abnormality not approved by the medical monitor prior to enrollment
  • Current use of experimental medications for AD (other than bapineuzumab) and all other experimental medications, herbal preparations containing Ginko biloba, and anticoagulants (except the use of aspirin 325mg/day or less, Plavix, and Persantine but not for stroke)

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Behandling
  • Tildeling: Randomisert
  • Intervensjonsmodell: Parallell tildeling
  • Masking: Firemannsrom

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Aktiv komparator: Bapineuzumab 0.5 mg/kg
0.5 mg/kg
Legemiddel: Bapineuzumab

0.5 mg/kg, administered via IV (in the vein) infusion every 13 weeks for 4 years.

1.0 mg/kg, administered via IV (in the vein) infusion every 13 weeks for 4 years.
Aktiv komparator: Bapineuzumab 1.0 mg/kg
1.0 mg/kg
Legemiddel: Bapineuzumab

0.5 mg/kg, administered via IV (in the vein) infusion every 13 weeks for 4 years.

1.0 mg/kg, administered via IV (in the vein) infusion every 13 weeks for 4 years.

Hva måler studien?

Primære resultatmål

Resultatmål
Tidsramme
Clinically important changes in safety assessment results including vital signs, weight, clinical laboratory tests, electrocardiograms (ECGs), brain magnetic resonance imaging (MRI), physical and neurological examinations, and infusion site assessments.
Tidsramme: Varies according to assessment: vital signs and adverse events on ongoing basis; MRI and ECG as required per protocol
Varies according to assessment: vital signs and adverse events on ongoing basis; MRI and ECG as required per protocol

Sekundære resultatmål

Resultatmål
Tidsramme
To evaluate the efficacy of long term treatment of IV administered bapineuzumab in subjects with AD.
Tidsramme: The trial duration is expected to be approximately 4 years. The study will last up to the time of commercial launch of bapineuzumab, or termination of the clinical trials program, whichever comes first
The trial duration is expected to be approximately 4 years. The study will last up to the time of commercial launch of bapineuzumab, or termination of the clinical trials program, whichever comes first

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Sponsor

JANSSEN Alzheimer Immunotherapy Research & Development, LLC

Samarbeidspartnere

Pfizer

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart

1. juli 2009

Primær fullføring (Faktiske)

1. september 2012

Studiet fullført (Faktiske)

1. september 2012

Datoer for studieregistrering

Først innsendt

7. juli 2009

Først innsendt som oppfylte QC-kriteriene

9. juli 2009

Først lagt ut (Anslag)

13. juli 2009

Oppdateringer av studieposter

Sist oppdatering lagt ut (Anslag)

20. desember 2013

Siste oppdatering sendt inn som oppfylte QC-kriteriene

26. november 2013

Sist bekreftet

1. november 2013

Mer informasjon

Begreper knyttet til denne studien

Nøkkelord

Ytterligere relevante MeSH-vilkår

Andre studie-ID-numre

  • ELN115727-351

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Kliniske studier på Bapineuzumab

Søk i lignende forsøk

Sponsorer og samarbeidspartnere

Medisinsk tilstand

Legemiddelintervensjoner

CROs by country

CROs in Kazakhstan

Forhold

Sjeldne sykdommer

Legemiddelintervensjoner

Kosttilskudd

Sponsor / samarbeidspartnere

Steder

Abonnere